Clinical studies recruiting near Xuzhou

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · The Affiliated Hospital of Xuzhou Medical University · Pfizer · NCT05020236 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · The Affiliated Hospital of Xuzhou Medical College ( Site 201 · Merck Sharp & Dohme LLC · NCT06136559 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · The Affiliated Hospital of Xuzhou Medical College · Pfizer · NCT06758401 IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NA · Affiliated Hospital of Xuzhou Medical University · Jinling Hospital, China · NCT06118840 Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Phase 2 · Xuzhou Central Hospital · Kunming Pharmaceuticals, Inc. · NCT07279493 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · The Affiliated Hospital of Xuzhou Medical University · Shanghai Henlius Biotech · NCT07160335 The Chinese Familial Alzheimer's Network
Phase N/A · Mineral General Hospital, Xuzhou · Capital Medical University · NCT03657732 Effect of Tegileridine Versus Sufentanil as Analgesic Components on Opioid-Induced Cough During Anesthesia Induction
NA · The First People's Hospital of Lianyungang · NCT07323043 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · The Affiliated Hospital of Xuzhou Medical University · Amgen · NCT07037433 A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor
Phase 1 · The Affiliated Hospital of Xuzhou Medical University · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT06615193 A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · XuZhou Central Hospital/Oncology Department · Turning Point Therapeutics, Inc. · NCT03093116 Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectiou
Phase N/A · Affiliated Hospital of Xuzhou Medical University · Huashan Hospital · NCT05965128 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · The Affiliated Hospital of Xuzhou Medical College · Pfizer · NCT07144280 A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Phase 1/Phase 2 · The Affiliated Hospital of Xuzhou Medical University · RemeGen Co., Ltd. · NCT07105215 A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-pos
Phase 1/Phase 2 · Xuzhou Central Hospital · Antengene Biologics Limited · NCT07327229 A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticit
Phase 3 · Xuzhou Medical University Affiliated Hospital · Chongqing Claruvis Pharmaceutical Co., Ltd. · NCT07478822 Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer
Phase 1/Phase 2 · The Affiliated Hospital of Xuzhou Medical University · The Affiliated Hospital of Xuzhou Medical University · NCT05211557 Clinical Studies for the Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · XuZhou Central Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06825494 The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management
NA · Research Site · AstraZeneca · NCT06909773 Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
NA · The Affiliated Hospital of Xuzhou Medical University · Capital Medical University · NCT07139301 A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants Wit
Phase 1 · The Affiliated Hospital of Xuzhou Medical University · BeOne Medicines · NCT06427941 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · The Affiliated Hospital of Xuzhou Medical University · Eli Lilly and Company · NCT06338995 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · The Affiliated Hospital of Xuzhou Medical University · Janssen Research & Development, LLC · NCT06319820 A Study of MI078 for Postpartum Depression
Phase 3 · Xuzhou Dongfang Hospital · Nanjing Minova Pharmaceutical Co., Ltd. · NCT07721961 Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Che
Phase 3 · The Affiliated Hospital of Xuzhou Medical University · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07165951 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo
Phase 3 · Xuzhou central hospital · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Xuzhou Central Hospital · Daiichi Sankyo · NCT06731478 A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carc
Phase 3 · The Affiliated Hospital of XuZhou Medical University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06860971

Look up another city

Look up another condition